Clinical Trial Update: AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas [Phase 2]

View source ↗

Summary

Phase 2 trial update for AZD2014 in Neurofibromatosis 2 patients with progressive or symptomatic meningiomas has completed; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma
• Neurofibromatosis Type 2

Drugs mentioned

• AZD2014 (vistusertib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatosis 2, Meningioma | Phase 2 | Status: COMPLETED | Results posted: 2020-12-22